NCT04739254View on ClinicalTrials.gov

Magnetocardiography Endocrine Registry

SuspendedOBSERVATIONAL

Enrollment

250

Participants

Timeline

Start Date

December 14, 2020

Primary Completion Date

May 1, 2022

Study Completion Date

May 1, 2030

Conditions

Endocrine Disorder

Interventions

DIAGNOSTIC_TEST

CardioFlux

Magnetocardiography

Trial Locations (1)

45040

Genetesis Facility, Mason

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Genetesis Inc.

INDUSTRY

NCT04739254 - Magnetocardiography Endocrine Registry | Biotech Hunter | Biotech Hunter